Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Feinberg

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
The American Journal of Managed Care|May 31, 2017
Real-world evidence and the behavioral economics of physician prescribingBruce Feinberg
JCO Oncology Practice|January 12, 2026
Pursuit of Hope Over ReasonBruce Feinberg
The American Journal of Managed Care|March 23, 2012
Clinical pathways for oncology: more rigor needed when evaluating modelsBruce Feinberg, Jeffrey Scott
Journal of Oncology Practice|October 19, 2012
Clinical pathways for oncology: more rigor needed when evaluating modelsBruce Feinberg, Jeffrey Scott
Health Affairs (Project Hope)|September 8, 2021
Biosimilars And Follow-On ProductsBruce Feinberg, Ajeet Gajra, Sonia Oskouei
The Oncologist|June 17, 2025
Real-world treatment patterns and outcomes of patients with hormone receptor-positive/HER2-low metastatic breast cancer treated with chemotherapySandhya Mehta, Jackie Kwong, Clara Lam, et al.
Anesthesia and Analgesia|May 29, 2002
Central neuraxial blockade promotes external cephalic version success after a failed attemptGerald Cherayil, Bruce Feinberg, Julian Robinson, et al.
Cancer Treatment and Research Communications|September 26, 2022
Real-world observational study of current treatment patterns and outcomes in recurrent or locally advanced/metastatic non-small cell lung cancerLyudmila Bazhenova, Jonathan Kish, Beilei Cai, et al.
Leukemia & Lymphoma|January 15, 2019
Treatment sequence of lenalidomide and hypomethylating agents and the impact on clinical outcomes for patients with myelodysplastic syndromesAmer M Zeidan, Andrew J Klink, Michael McGuire, et al.
The American Journal of Managed Care|June 19, 2019
Reports of the demise of chemotherapy have been greatly exaggeratedBruce Feinberg, Jonathan Kish, Igoni Dokubo, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
The American Journal of Managed Care|May 31, 2017
Real-world evidence and the behavioral economics of physician prescribingBruce Feinberg
JCO Oncology Practice|January 12, 2026
Pursuit of Hope Over ReasonBruce Feinberg
The American Journal of Managed Care|March 23, 2012
Clinical pathways for oncology: more rigor needed when evaluating modelsBruce Feinberg, Jeffrey Scott
Journal of Oncology Practice|October 19, 2012
Clinical pathways for oncology: more rigor needed when evaluating modelsBruce Feinberg, Jeffrey Scott
Health Affairs (Project Hope)|September 8, 2021
Biosimilars And Follow-On ProductsBruce Feinberg, Ajeet Gajra, Sonia Oskouei
The Oncologist|June 17, 2025
Real-world treatment patterns and outcomes of patients with hormone receptor-positive/HER2-low metastatic breast cancer treated with chemotherapySandhya Mehta, Jackie Kwong, Clara Lam, et al.
Anesthesia and Analgesia|May 29, 2002
Central neuraxial blockade promotes external cephalic version success after a failed attemptGerald Cherayil, Bruce Feinberg, Julian Robinson, et al.
Cancer Treatment and Research Communications|September 26, 2022
Real-world observational study of current treatment patterns and outcomes in recurrent or locally advanced/metastatic non-small cell lung cancerLyudmila Bazhenova, Jonathan Kish, Beilei Cai, et al.
Leukemia & Lymphoma|January 15, 2019
Treatment sequence of lenalidomide and hypomethylating agents and the impact on clinical outcomes for patients with myelodysplastic syndromesAmer M Zeidan, Andrew J Klink, Michael McGuire, et al.
The American Journal of Managed Care|June 19, 2019
Reports of the demise of chemotherapy have been greatly exaggeratedBruce Feinberg, Jonathan Kish, Igoni Dokubo, et al.
Pageof 5